Investing
Top Day Trader Alerts (BBY, BCRX, C, DNDN, ING, LXRX, YHOO)
Published:
Last Updated:
These are this morning’s top pre-market day trader alert stocks. We have more color and more detail on price and volume analysis linked through to each at VSInvestor.com:
Best Buy Co. (NYSE: BBY) is holding up better than many might guess considering how much it has run up. This is after light earnings.
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is fairly close to 52-week highs after signing three partnerships for Peramivir for influenza outside the U.S.
Citigroup Inc. (NYSE: C) is down but only marginally on reports of a ‘possible’ stake sale by The U.S. Government.
Dendreon Corp. (NASDAQ: (DNDN) is giving back a portion of yesterday’s gains on merger rumors.
ING Group (NYSE: ING) will be an active ADR today after the EU may block a settlement.
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is surging as a top bio-winner after moving to Phase 2 clinical trial of LX4211 in patients with type 2 diabetes.
Yahoo! Inc. (NASDAQ: YHOO) is soaring to highs not seen since July on yet another upgrade.
You can join our open email distribution list which goes out several times per week for top day trader alerts, top analyst upgrades and downgrades, IPO’s, key secondary offerings, guru investor data on Buffett and others, mergers, and more.
JON C. OGG
September 15, 2009
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
